AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | -66.7% | 90,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $15,000 | -64.3% | 90,000 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $42,000 | -17.6% | 90,000 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $51,000 | -65.8% | 90,000 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $149,000 | -0.7% | 90,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $150,000 | -1.3% | 90,000 | 0.0% | 0.01% | -7.7% |
| Q1 2021 | $152,000 | +6.3% | 90,000 | 0.0% | 0.01% | -7.1% |
| Q4 2020 | $143,000 | +66.3% | 90,000 | 0.0% | 0.01% | +40.0% |
| Q3 2020 | $86,000 | +50.9% | 90,000 | 0.0% | 0.01% | +42.9% |
| Q2 2020 | $57,000 | +35.7% | 90,000 | -10.0% | 0.01% | +16.7% |
| Q1 2020 | $42,000 | -27.6% | 100,000 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $58,000 | +16.0% | 100,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $50,000 | +28.2% | 100,000 | 0.0% | 0.01% | +20.0% |
| Q2 2019 | $39,000 | -30.4% | 100,000 | 0.0% | 0.01% | -28.6% |
| Q1 2019 | $56,000 | +43.6% | 100,000 | 0.0% | 0.01% | +16.7% |
| Q4 2018 | $39,000 | -23.5% | 100,000 | 0.0% | 0.01% | -14.3% |
| Q3 2018 | $51,000 | -76.8% | 100,000 | 0.0% | 0.01% | -77.4% |
| Q2 2018 | $220,000 | -35.3% | 100,000 | 0.0% | 0.03% | -35.4% |
| Q1 2018 | $340,000 | -16.5% | 100,000 | 0.0% | 0.05% | -17.2% |
| Q4 2017 | $407,000 | +567.2% | 100,000 | 0.0% | 0.06% | +544.4% |
| Q3 2017 | $61,000 | +17.3% | 100,000 | 0.0% | 0.01% | +12.5% |
| Q2 2017 | $52,000 | -35.0% | 100,000 | 0.0% | 0.01% | -42.9% |
| Q1 2017 | $80,000 | -1.2% | 100,000 | +11.1% | 0.01% | -6.7% |
| Q4 2016 | $81,000 | +20.9% | 90,000 | 0.0% | 0.02% | +7.1% |
| Q3 2016 | $67,000 | -42.2% | 90,000 | 0.0% | 0.01% | -44.0% |
| Q2 2016 | $116,000 | -42.9% | 90,000 | 0.0% | 0.02% | -45.7% |
| Q1 2016 | $203,000 | -11.0% | 90,000 | +38.5% | 0.05% | -16.4% |
| Q4 2015 | $228,000 | +21.3% | 65,000 | 0.0% | 0.06% | +12.2% |
| Q3 2015 | $188,000 | +17.5% | 65,000 | +18.2% | 0.05% | +25.6% |
| Q2 2015 | $160,000 | -64.6% | 55,000 | -8.3% | 0.04% | -66.9% |
| Q1 2015 | $452,000 | +148.4% | 60,000 | +13.2% | 0.12% | +136.0% |
| Q4 2014 | $182,000 | +2.8% | 53,000 | +6.0% | 0.05% | -3.8% |
| Q3 2014 | $177,000 | -57.7% | 50,000 | 0.0% | 0.05% | -57.7% |
| Q2 2014 | $418,000 | +31.4% | 50,000 | 0.0% | 0.12% | +21.8% |
| Q1 2014 | $318,000 | -10.9% | 50,000 | 0.0% | 0.10% | -14.4% |
| Q4 2013 | $357,000 | +19.0% | 50,000 | +25.0% | 0.12% | +8.3% |
| Q3 2013 | $300,000 | +29.9% | 40,000 | 0.0% | 0.11% | +18.5% |
| Q2 2013 | $231,000 | – | 40,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|